Yüklüyor......
Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy Related Toxicities
Chimeric antigen receptor T-cell (CAR-T) therapy has proven to be a very effective cancer immunotherapy. Axicabtagene ciloleucel and Tisagenlecleucel are the first in class anti-CD19 CAR-T-cells currently available for relapsed-refractory adult large B-cell lymphoma. Tisagenlecleucel is also availab...
Kaydedildi:
| Yayımlandı: | BioDrugs |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733400/ https://ncbi.nlm.nih.gov/pubmed/30560413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0324-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|